buprenorphine hydrochloride and naloxone hydrochloride dihydrate

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 70518-3862
  • Package NDC 70518-3862-0
  • Application number ANDA203326
  • SPL ID 5942b633-c7a1-4ef7-e063-6394a90ab2a5
  • SPL set ID 43027750-d218-49e5-867f-c941736d2056
  • UNII 56W8MW3EN1
  • UNII 5Q187997EE
  • RxCUI 351266

What the source publishes

Labeler
REMEDYREPACK INC.
Active ingredients
buprenorphine hydrochloride and naloxone hydrochloride dihydrate
Form
TABLET
Routes
SUBLINGUAL
Administrative status
present-in-source-snapshot
Marketing status
ANDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:70518-3862_5942b633-c7a1-4ef7-e063-6394a90ab2a5
{
  "name": "buprenorphine hydrochloride and naloxone hydrochloride dihydrate",
  "splId": "5942b633-c7a1-4ef7-e063-6394a90ab2a5",
  "labels": [
    {
      "setId": "43027750-d218-49e5-867f-c941736d2056",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=43027750-d218-49e5-867f-c941736d2056",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=43027750-d218-49e5-867f-c941736d2056"
    }
  ],
  "routes": [
    "SUBLINGUAL"
  ],
  "labeler": "REMEDYREPACK INC.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "30 TABLET in 1 BLISTER PACK (70518-3862-0)",
      "package_ndc": "70518-3862-0",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20230915"
    }
  ],
  "productId": "70518-3862_5942b633-c7a1-4ef7-e063-6394a90ab2a5",
  "useDomain": "unknown",
  "dosageForm": "TABLET",
  "productNdc": "70518-3862",
  "deaSchedule": "CIII",
  "genericName": "buprenorphine hydrochloride and naloxone hydrochloride dihydrate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "BUPRENORPHINE HYDROCHLORIDE",
      "strength": "2 mg/1"
    },
    {
      "name": "NALOXONE HYDROCHLORIDE DIHYDRATE",
      "strength": ".5 mg/1"
    }
  ],
  "applicationNumber": "ANDA203326",
  "marketingCategory": "ANDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20230915",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "56W8MW3EN1",
      "5Q187997EE"
    ],
    "rxcui": [
      "351266"
    ],
    "spl_set_id": [
      "43027750-d218-49e5-867f-c941736d2056"
    ],
    "manufacturer_name": [
      "REMEDYREPACK INC."
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:70518-3862_5942b633-c7a1-4ef7-e063-6394a90ab2a5"